FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Günter Brittinger

Research Profile

Disorders

Procedures

Chemicals & Drugs

Anatomy

B-Lymphocytes

Concepts & Ideas

Co-author Network

Publications

TOP 3
Peter Dreger; Ulrich Dührsen; Anna-Maria Fink; Hildegard Greinix; Michael Hallek; Manfred Hensel; Wolfgang Knauf; Michael Kneba; Fabienne McClanahan; Michael Pfreundschuh; Matthias Ritgen; Johannes Schetelig; Norbert Schmitz; Michael Stadler; Stephan Stilgenbauer; Dirk Winkler; Günter Brittinger; Andreas Bühler; Raymonde Busch; Hartmut Döhner
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
Ulrich Dührsen; Christian P Kratz; Christian Flotho; Thomas C Lauenstein; Martin Bommer; Erika König; Günter Brittinger; Hermann Heimpel
Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.
Barbara F Eichhorst; Raymonde Busch; Stephan Stilgenbauer; Martina Stauch; Manuela A Bergmann; Matthias Ritgen; Nicole Kranzhöfer; Robert Rohrberg; Ulrike Söling; Oswald Burkhard; Anne Westermann; Valentin Goede; Carmen Schweighofer; Kirsten Fischer; Anna-Maria Fink; Clemens-Martin Wendtner; Günter Brittinger; Hartmut Döhner; Bertold Emmerich; Michael Hallek
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Günter Brittinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Peter Dreger; Ulrich Dührsen; Anna-Maria Fink; Hildegard Greinix; Michael Hallek; Manfred Hensel; Wolfgang Knauf; Michael Kneba; Fabienne McClanahan; Michael Pfreundschuh; Matthias Ritgen; Johannes Schetelig; Norbert Schmitz; Michael Stadler; Stephan Stilgenbauer; Dirk Winkler; Günter Brittinger; Andreas Bühler; Raymonde Busch; Hartmut Döhner
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
Blood 2012;119(21):4851-9.
2011: Ulrich Dührsen; Christian P Kratz; Christian Flotho; Thomas C Lauenstein; Martin Bommer; Erika König; Günter Brittinger; Hermann Heimpel
Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.
Annals of hematology 2011;90(3):301-6.
2009: Barbara F Eichhorst; Raymonde Busch; Stephan Stilgenbauer; Martina Stauch; Manuela A Bergmann; Matthias Ritgen; Nicole Kranzhöfer; Robert Rohrberg; Ulrike Söling; Oswald Burkhard; Anne Westermann; Valentin Goede; Carmen Schweighofer; Kirsten Fischer; Anna-Maria Fink; Clemens-Martin Wendtner; Günter Brittinger; Hartmut Döhner; Bertold Emmerich; Michael Hallek
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Blood 2009;114(16):3382-91.
2009: Annina Herrmann; Eva Hoster; Thomas Zwingers; Günter Brittinger; Marianne Engelhard; Peter Meusers; Marcel Reiser; Roswitha Forstpointner; Bernd Metzner; Norma Peter; Bernhard Wörmann; Lorenz Trümper; Michael Pfreundschuh; Hermann Einsele; Wolfgang Hiddemann; Michael Unterhalt; Martin Dreyling
Improvement of overall survival in advanced stage mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):511-8.
2006: Barbara F Eichhorst; Raymonde Busch; Georg Hopfinger; Rita Pasold; Manfred Hensel; Cordelia Steinbrecher; Siegfried Siehl; Ulrich Jäger; Manuela Bergmann; Stephan Stilgenbauer; Carmen Schweighofer; Clemens-Martin Wendtner; Hartmut Döhner; Günter Brittinger; Bertold Emmerich; Michael Hallek
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.
Blood 2006;107(3):885-91.
2006: Carsten Schrader; Peter Meusers; Günter Brittinger; Dirk Janssen; Afshin Teymoortash; Jens U Siebmann; Reza Parwaresch; Markus Tiemann
Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients.
Virchows Archiv : an international journal of pathology 2006;448(2):151-9.
2005: Carsten Schrader; Dirk Janssen; Peter Meusers; Günter Brittinger; Jens U Siebmann; Reza Parwaresch; Markus Tiemann
Repp86: a new prognostic marker in mantle cell lymphoma.
European journal of haematology 2005;75(6):498-504.
2005: Carsten Schrader; Dirk Janssen; Wolfram Klapper; Jens U Siebmann; Peter Meusers; Günter Brittinger; Michael Kneba; Markus Tiemann; Reza Parwaresch
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.
British journal of cancer 2005;93(8):939-45.
2004: Carsten Schrader; Peter Meusers; Günter Brittinger; Afshin Teymoortash; Jens U Siebmann; Dirk Janssen; Reza Parwaresch; Markus Tiemann
Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.
Leukemia 2004;18(7):1200-6.
2002: Michael Hallek; Manuela Bergmann; Günter Brittinger; Hartmut Döhner; P Dreger; M Herold; Georg Hopfinger; Ulrich Jäger; Wolfgang Knauf; Christoph Nerl; M Rummel; Barbara Schmitt; Clemens-Martin Wendtner; Bertold Emmerich
[Chronic lymphatic leukemia. Current therapy concepts].
Der Internist 2002;43(10):1245-54.
2002: Jorg Basecke; Lukas Cepek; Christine Mannhalter; Jürgen Krauter; Stefanie Hildenhagen; Günter Brittinger; Lorenz Trumper; Frank Griesinger
Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia.
Blood 2002;100(6):2267-8.
2002: Jörg Bäsecke; Michaela Feuring-Buske; Günter Brittinger; U W Schaefer; Wolfgang Hiddemann; Frank Griesinger
Transcription of AML1 in hematopoietic subfractions of normal adults.
Annals of hematology 2002;81(5):254-7.
2002: Thomas M Behr; Torsten Liersch; Lutz Greiner-Bechert; Frank Griesinger; Martin Béhé; Peter M Markus; Stefan Gratz; Christa Angerstein; Günter Brittinger; Heinz Becker; David M Goldenberg; Wolfgang Becker
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.
Cancer 2002;94(4 Suppl):1373-81.
2002: Thomas M Behr; Frank Griesinger; Joachim Riggert; Stefan Gratz; Martin Béhé; Cornelia C Kaufmann; Bernhard Wörmann; Günter Brittinger; Wolfgang Becker
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study.
Cancer 2002;94(4 Suppl):1363-72.
2002: Jörg Bäsecke; Frank Griesinger; Lorenz Trümper; Günter Brittinger
Leukemia- and lymphoma-associated genetic aberrations in healthy individuals.
Annals of hematology 2002;81(2):64-75.
2002: Michael Uppenkamp; A Engert; V Diehl; D Bunjes; D Huhn; Günter Brittinger
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study.
Annals of hematology 2002;81(1):26-32.
2001: Michael Hallek; Barbara Schmitt; Martin Wilhelm; Raymonde Busch; A Kröber; H P Fostitsch; O Sezer; M Herold; Wolfgang Knauf; Clemens-Martin Wendtner; R Kuse; Mathias Freund; A Franke; F Schriever; Christoph Nerl; Hartmut Döhner; Eckhard Thiel; Wolfgang Hiddemann; Günter Brittinger; Bertold Emmerich
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.
British journal of haematology 2001;114(2):342-8.
2000: Michael Flasshove; Peter Meusers; Jochen Schütte; Richard Noppeney; Dietrich Beelen; S Sohrab; U Roggenbuck; G Kemmeries; Günter Brittinger; Siegfried Seeber; Max E Scheulen
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia.
Annals of hematology 2000;79(10):533-42.
2000: Walter Verbeek; M Faulhaber; Frank Griesinger; Günter Brittinger
Measurement of thrombopoietic levels: clinical and biological relationships.
Current opinion in hematology 2000;7(3):143-9.
2000: B Gahn; Günter Brittinger; G Dölken; Hartmut Döhner; Bertold Emmerich; A Franke; Mathias Freund; C Huber; R Kuse; T Scholten; Wolfgang Hiddemann
Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia.
Leukemia & lymphoma 2000;37(1-2):169-73.
1999: R Moog; Michael Uppenkamp; H Böck; N Müller; Günter Brittinger
Harvesting of peripheral blood progenitor cells with different programmes of discontinuous flow systems.
Vox sanguinis 1999;76(1):50-4.
1998: M Cohnen; Michael Uppenkamp; Peter Meusers; Günter Brittinger
[POEMS syndrome. A rare variant of osteosclerotic multiple myeloma with polyneuropathy, organomegaly, endocrinopathy, M-gradient and skin lesions].
Medizinische Klinik (Munich, Germany : 1983) 1998;93(11):678-82.
1998: Michael Uppenkamp; E Makarova; S Petrasch; Günter Brittinger
Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis.
Annals of hematology 1998;77(5):217-23.
1998: Sabine Kasimir-Bauer; H Ottinger; Peter Meusers; Dietrich Beelen; Günter Brittinger; Siegfried Seeber; Max E Scheulen
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy.
Experimental hematology 1998;26(12):1111-7.
1998: J Lundin; Anders Osterborg; Günter Brittinger; D Crowther; H Dombret; A Engert; A Epenetos; C Gisselbrecht; D Huhn; U Jaeger; J Thomas; R Marcus; N Nissen; C Poynton; E Rankin; R Stahel; Michael Uppenkamp; R Willemze; Håkan Mellstedt
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3257-63.
1998: Peter Meusers; Günter Brittinger
[R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Praxis 1998;87(23):793-800.
1997: S Petrasch; O Kühnemund; A Reinacher; Michael Uppenkamp; Ralf Rene Reinert; Wolff Schmiegel; Rudolf Lütticken; Günter Brittinger
Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.
Clinical and diagnostic laboratory immunology 1997;4(6):635-8.
1997: Peter Meusers; J Hense; Günter Brittinger
Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems.
Leukemia 1997;11 Suppl 2():S60-4.
1997: M Engelhard; Günter Brittinger; D Huhn; HH Gerhartz; Peter Meusers; W Siegert; E Thiel; W Wilmanns; Uelker Aydemir; S Bierwolf; H Griesser; Markus Tiemann; K Lennert
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Blood 1997;89(7):2291-7.
1996: Rainer Haas; Günter Brittinger; Peter Meusers; S Murea; Hartmut Goldschmidt; Michael Wannenmacher; W Hunstein
Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma.
Leukemia 1996;10(12):1975-9.
1996: C Teschendorf; G Trenn; HG Höffkes; Günter Brittinger
Differential effect of the activation of protein kinase A on the protein synthesis and secretion in the T-helper 2 cell line D10.G4.1.
Scandinavian journal of immunology 1996;44(2):150-6.
1996: HG Höffkes; Günter Brittinger; Astrid Franke
Immunophenotyping of acute leukaemias and non-Hodgkin's lymphoma--review of ongoing consensus protocols.
European journal of medical research 1996;1(9):433-8.
1996: M Knippschild; EN Schmid; Michael Uppenkamp; E König; Peter Meusers; Günter Brittinger; HG Höffkes
Infection by Alcaligenes xylosoxidans subsp. xylosoxidans in neutropenic patients.
Oncology 1996;53(3):258-62.
1996: HG Höffkes; G Schmidtke; U Schmucker; Günter Brittinger
Lymphocyte gating of peripheral blood in patients with leukemic low-grade non-Hodgkin's lymphoma by multiparametric flow cytometry.
European journal of medical research 1996;1(4):215-22.
1995: HG Höffkes; G Schmidtke; U Schmücker; Michael Uppenkamp; Günter Brittinger
Immunophenotyping of B lymphocytes by multiparametric flow cytometry in bone marrow aspirates and peripheral blood of healthy adults.
European journal of medical research 1995;1(1):2-8.
1995: Wolfgang Siegert; Christoph Nerl; Alexander Agthe; M Engelhard; Günter Brittinger; Markus Tiemann; K Lennert; Dieter Huhn
Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(7):659-64.
1995: HG Höffkes; G Schmidtke; U Schmücker; Michael Uppenkamp; Günter Brittinger
Immunophenotyping of B lymphocytes by multiparametric flow cytometry in bone marrow aspirates of healthy adults.
Annals of hematology 1995;71(3):123-8.
1995: HG Höffkes; A Schumann; Michael Uppenkamp; C Teschendorf; A E Schindler; R Parwaresch; Günter Brittinger
Primary non-Hodgkin's lymphoma of the vagina. Case report and review of the literature.
Annals of hematology 1995;70(5):273-6.
1995: HG Höffkes; F Weber; Michael Uppenkamp; Peter Meusers; C Teschendorf; Thomas Philipp; Günter Brittinger
Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange.
Seminars in thrombosis and hemostasis 1995;21(2):161-5.
1994: M Engelhard; Günter Brittinger
Clinical relevance of granulocyte-macrophage colony-stimulating factor.
Seminars in oncology 1994;21(6 Suppl 16):1-4.
1994: HH Gerhartz; M Engelhard; Günter Brittinger; Günter Schlimok; Eckhard Thiel; C Huber; B Emmerich; C Schadek; R Brandmaier; A C Stern
Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
Seminars in oncology 1994;21(6 Suppl 16):25-8.
1994: S Petrasch; Günter Brittinger; H H Wacker; J Schmitz; M Kosco-Vilbois
Follicular dendritic cells in non-Hodgkin's lymphomas.
Leukemia & lymphoma 1994;15(1-2):33-43.
1994: Wolfgang Siegert; Christoph Nerl; M Engelhard; Günter Brittinger; Markus Tiemann; R Parwaresch; R Heinz; Dieter Huhn
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
British journal of haematology 1994;87(3):529-34.
1994: Sabine Kasimir-Bauer; Hellmut D Ottinger; Günter Brittinger; W König
Philadelphia chromosome-positive chronic myelogenous leukemia: functional defects in circulating mature neutrophils of untreated and interferon-alpha-treated patients.
Experimental hematology 1994;22(5):426-31.
1994: M Engelhard; HH Gerhartz; Günter Brittinger; A Engert; R Fuchs; B Geiseler; D Gerhartz; A R Haunauske; H J Hartlapp; Dieter Huhn
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():123-5.
1993: HH Gerhartz; M Engelhard; Peter Meusers; Günter Brittinger; W Wilmanns; Günter Schlimok; P Mueller; Dieter Huhn; R Musch; Wolfgang Siegert
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas.
Blood 1993;82(8):2329-39.
1993: Michael Uppenkamp; K Schepers; I G Dresen; Peter Meusers; Günter Brittinger
Regulation of the T cell receptor-alpha mRNA expression in the human lymphoblastic T cell line CEM.
Experimental hematology 1993;21(2):331-7.
1992: S Petrasch; M Kosco; J Schmitz; H H Wacker; Günter Brittinger
Follicular dendritic cells in non-Hodgkin-lymphoma express adhesion molecules complementary to ligands on neoplastic B-cells.
British journal of haematology 1992;82(4):695-700.
1992: Wolfgang Siegert; Alexander Agthe; H Griesser; R Schwerdtfeger; Günter Brittinger; M Engelhard; R Kuse; Markus Tiemann; K Lennert; Dieter Huhn
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.
Annals of internal medicine 1992;117(5):364-70.
1992: G Trenn; J Sykora; M C Michel; Günter Brittinger
Functional and biochemical characterization of a calcium-ionophore-induced state of unresponsiveness in a cytolytic T cell clone.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(5):1338-46.
1992: S Petrasch; M Kosco; C Perez-Alvarez; J Schmitz; Günter Brittinger
Proliferation of non-Hodgkin-lymphoma lymphocytes in vitro is dependent upon follicular dendritic cell interactions.
British journal of haematology 1992;80(1):21-6.
1991: S Petrasch; M H Kosco; C J Perez-Alvarez; J Schmitz; Günter Brittinger
Proliferation of germinal center B lymphocytes in vitro by direct membrane contact with follicular dendritic cells.
Immunobiology 1991;183(5):451-62.
1991: M Engelhard; Peter Meusers; Günter Brittinger; N Brack; W Dornoff; W Enne; W Gassmann; HH Gerhartz; M Hallek; J Heise
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():177-80.
1991: S Petrasch; H Stein; M H Kosco; Günter Brittinger
Follicular dendritic cells in non-Hodgkin lymphomas: localisation, characterisation and pathophysiological aspects.
European journal of cancer (Oxford, England : 1990) 1991;27(8):1052-6.
1990: Michael Uppenkamp; Peter Meusers; K Donhuijsen; Günter Brittinger
[Benzene-associated myelofibrosis at an early stage].
Der Internist 1990;31(12):769-72.
1990: S Petrasch; C Perez-Alvarez; J Schmitz; M Kosco; Günter Brittinger
Antigenic phenotyping of human follicular dendritic cells isolated from nonmalignant and malignant lymphatic tissue.
European journal of immunology 1990;20(5):1013-8.
1990: Hellmut D Ottinger; S Petrasch; R Püllen; Günter Brittinger
[Significance of immunophenotyping of blood and cerebrospinal fluid lymphocytes for the diagnosis of leukemic meningosis in a patient with chronic lymphatic leukemia of the B-cell type].
Medizinische Klinik (Munich, Germany : 1983) 1990;85 Suppl 1():141-3.
1989: S Petrasch; H H Wacker; P Zou; D Bechtold; Günter Brittinger
Enhancement in number and function of antigen-presenting cells in the lymphatic tissue of rats after in vivo administration of diphenylhydantoin (DPH).
Clinical and experimental immunology 1989;78(1):133-7.
1989: HH Gerhartz; W Wilmanns; Günter Brittinger; M Engelhard; R Heinz; Dieter Huhn; Peter Meusers; Wolfgang Siegert; A Stacher; Eckhard Thiel
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study].
Onkologie 1989;12(1):22-6.
1988: U Dührsen; Michael Uppenkamp; Peter Meusers; E König; Günter Brittinger
Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias.
Blut 1988;56(3):97-102.
1988: HH Gerhartz; Eckhard Thiel; Günter Brittinger; B Dörken; M Engelhard; W Engert; W Enne; R Fuchs; C H Hagen-Aukamp; Dieter Huhn
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Blut 1988;56(3):139-42.
1988: Wolfgang Siegert; Dieter Huhn; A Neubauer; Günter Brittinger; M Engelhard; HH Gerhartz; R Heinz; Peter Meusers; A Stacher; Eckhard Thiel
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results].
Onkologie 1988;11(1):30-4.
1987: U Dührsen; W Augener; T Zwingers; Günter Brittinger
Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases.
British journal of haematology 1987;67(2):235-9.
1987: U Dührsen; D Paar; C Kölbel; A Boekstegers; U Metz-Kurschel; R Wagner; W Kirch; Peter Meusers; E König; Günter Brittinger
Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.
Klinische Wochenschrift 1987;65(18):852-9.
1987: U Dührsen; D Paar; Günter Brittinger
Lupus anticoagulant associated syndrome in benign and malignant systemic disease.
Klinische Wochenschrift 1987;65(17):818-22.
1986: Günter Brittinger; Peter Meusers; M Engelhard
[Strategies in the treatment of non-Hodgkin's lymphomas].
Der Internist 1986;27(8):485-97.
1986: U Dührsen; Michael Uppenkamp; I Uppenkamp; R Becher; M Engelhard; E König; Peter Meusers; S Meuer; Günter Brittinger
Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia.
Blood 1986;68(2):577-85.
1986: Günter Brittinger; H Bartels; H Common; E Dühmke; M Engelhard; H H Fülle; U Gunzer; T Gyenes; R Heinz; E König
[Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas].
Onkologie 1986;9(2):118-25.
1985: U Dührsen; Peter Meusers; E Gries; Günter Brittinger
Long-lasting remission of hairy cell leukemia after eight weeks' therapy with low-dose alpha-(leucocyte-)interferon.
Blut 1985;51(4):297-8.
1985: W Augener; B Friedmann; Günter Brittinger
Are aggregates of IgG the effective part of high-dose immunoglobulin therapy in adult idiopathic thrombocytopenic purpura (ITP)?
Blut 1985;50(4):249-52.
1985: Peter Meusers; H Heidemann; C Lunscken; Michael Uppenkamp; P Zou; Günter Brittinger
[High-dose cytarabine treatment: a promising therapy modality in acute resistant myeloid leukemias in recurrence].
Onkologie 1985;8(1):16, 18-9.
1984: Günter Brittinger; H Bartels; H Common; E Dühmke; H H Fülle; U Gunzer; T Gyenes; R Heinz; E König; Peter Meusers
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
Hematological oncology 1984;2(3):269-306.
1983: H Huber; C Gattringer; Monika Lechleitner; T Gyenes; H Frommhold; Günter Brittinger; H Braunsteiner
[Therapy of malignant lymphomas].
Wiener klinische Wochenschrift 1983;95(4):93-112.
1981: U Schmalhorst; H Bartels; I Boll; A Burger-Schüler; H Common; H H Fülle; M Graubner; R Heinz; Dieter Huhn; H Leopold; Peter Meusers; L Nowicki; R Nürnberger; J Oertel; Ursula Rühl; G Sieber; M Schmidt; A Schoengen; A Strassner; EW Schwarze; Günter Brittinger
Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy.
Blut 1981;43(3):201-11.
1981: E König; H Bartels; K Bremer; A Burger-Schüler; H Common; E Dühmke; M Engelhard; H H Fülle; U Gunzer; K M Koeppen; H Leopold; L Nowicki; J Oertel; S Paetzmann; Ursula Rühl; M Schmidt; A Schoengen; H Scholle; A Stacher; B Wolf-Hornung; EW Schwarze; Günter Brittinger
Germinal center cell lymphomas: prognostic significance of their histopathological differentiation.
Blut 1981;43(3):193-200.
1981: R Heinz; A Stacher; H Pralle; H Theml; F Brunswicker; M Burkert; H Common; H H Fülle; T Grisar; A Grüneisen; F Herrmann; H Leopold; R Liffers; Peter Meusers; L Nowicki; R Nürnberger; H Rengshausen; Ursula Rühl; A Schoengen; M Schmidt; R Wirthmüller; EW Schwarze; Günter Brittinger
Lymphoplasmacytic/lymphoplasmacytoid lymphoma: a clinical entity distinct from chronic lymphocytic leukaemia?
Blut 1981;43(3):183-92.
1981: G R Krüger; T Grisar; K Lennert; EW Schwarze; Günter Brittinger
Histopathological correlation of the Kiel with the original Rappaport classification of malignant non-hodgkin lymphomas.
Blut 1981;43(3):167-81.
1981: Günter Brittinger; U Schmalhorst; H Bartels; H H Fülle; HH Gerhartz; G Gremmel; T Grisar; H J Grupp; U Gunzer; Dieter Huhn; K M Koeppen; B Kubanek; H Leopold; Helmut Löffler; G W Löhr; L Nowicki; Ursula Rühl; M Schmidt; A Stacher; H Theml; K Lennert
Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification.
Blut 1981;43(3):155-66.
1981: Peter Meusers; E König; Günter Brittinger
Clinical aspects on non-cutaneous T-lymphomas.
Pathology, research and practice 1981;171(2):216-39.
1980: Peter Meusers; E König; Günter Brittinger
Why not adhere to the original Kiel classification?
Lancet 1980;2(8205):1194.